FDA OKs Pfizer's Lipitor for use in diabetics
3rd Oct 2005, 01:51 GMT
Pfizer Inc. said on Tuesday U.S. regulators have approved its blockbuster cholesterol drug Lipitor to reduce the risk of Stroke and Heart Attack in diabetic patients. Pfizer said the approval is...
FDA OKs Pfizer's Lipitor for use in diabetics related news:
- FDA lässt Pfizer-Krebsmedikament Aromasin für neue Anwendung zu — Finanztreff.de / BRANCHEN
- Market Pulse: Pfizer gets FDA ok for Aromasin as adjuvant treatment — Operations-Related News from StratCenter.com
- Pfizer Plays A Guessing Game — Forbes.com Science and Medicine News
- FDA Approves Pfizer Request To Market Breast Cancer Drug ... — Pfizer
- Pfizer Cancer Drug Gets Wider Approval — Operations-Related News from StratCenter.com
- Mylan Gets FDA OK for Generic Norvasc — Government/ Industry Regulation News from StratCenter.com
- Mylan erhält endgültige FDA-Zulassung für Norvasc-Generikum — Finanztreff.de / NACHRICHTEN
- Pfizer erhält erneute Aromasin-Zulassung von der FDA — Newsticker - Berliner Morgenpost
- FDA OKs 2 New Uses for Arthritis Drug Humira — WebMD Health Headlines
- FDA approves Pfizer's adjuvant breast cancer treatment — Pharmaceutical Business Review Online
Latest news from Health News Online - Medical and health information and tools from Armenian Medical Network:
- Mobile Robots Offer 24/7 Care to Neurosurgical ICU, Stroke Patients
- How Diet, Obesity and Even Gum Disease May Affect Immune System
- New Guideline for the Diagnostic Assessment of Children with Continuous Seizures
- EU wants safer cigarettes to reduce fires
- Pharmacy care programs for elderly improve health outcomes
- More U.S residents trust TV for health inf
- Scientists use pixels to ease amputees' pain
- Tamiflu label will carry new caution in U.S.
- Dad's vocabulary affects child's language skills
- Chocolate 'Offenders' Teach Science a Sweet Lesson